SlideShare ist ein Scribd-Unternehmen logo
1 von 13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides
Published on November 2012

                                                                                                            Report Summary

Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals
industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and
profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.


Scope of the Report


* Contains an executive summary and data on value, volume and segmentation


* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies


* Incorporates in-depth five forces competitive environment analysis and scorecards


* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan,
the UK and the US).


* Includes a five-year forecast of the industry


Highlights


The global pharmaceuticals market grew by 3.5% in 2011 to reach a value of $782.1 billion.


In 2016, the global pharmaceuticals market is forecast to have a value of $971.1 billion, an increase of 24.2% since 2011.


Americas accounts for 42.2% of the global pharmaceuticals market value.


Pfizer is the leading player in the global pharmaceuticals market, generating a 8.7% share of the market's value.


Why you should buy this report


* Spot future trends and developments


* Inform your business decisions


* Add weight to presentations and marketing materials


* Save time carrying out entry-level research


Market Definition


The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                           Page 1/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency
conversions used in the production of this report have been calculated at constant 2011 annual average exchange rates.




                                                                                                             Table of Content

TABLE OF CONTENTS


EXECUTIVE SUMMARY 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Introduction 19
What is this report about' 19
Who is the target reader' 19
How to use this report 19
Definitions 19
Global Pharmaceuticals 20
Market Overview 20
Market Data 21
Market Segmentation 22
Market outlook 24
Five forces analysis 25
Pharmaceuticals in Asia-Pacific 33
Market Overview 33
Market Data 34
Market Segmentation 35
Market outlook 37
Five forces analysis 38
Pharmaceuticals in Europe 46
Market Overview 46
Market Data 47
Market Segmentation 48
Market outlook 50
Five forces analysis 51
Pharmaceuticals in France 59
Market Overview 59
Market Data 60
Market Segmentation 61
Market outlook 63
Five forces analysis 64
Macroeconomic indicators 72
Pharmaceuticals in Germany 74
Market Overview 74
Market Data 75
Market Segmentation 76



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                           Page 2/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Market outlook 78
Five forces analysis 79
Macroeconomic indicators 87
Pharmaceuticals in Italy 89
Market Overview 89
Market Data 90
Market Segmentation 91
Market outlook 93
Five forces analysis 94
Macroeconomic indicators 102
Pharmaceuticals in Japan 104
Market Overview 104
Market Data 105
Market Segmentation 106
Market outlook 108
Five forces analysis 109
Macroeconomic indicators 117
Pharmaceuticals in Belgium 119
Market Overview 119
Market Data 120
Market Segmentation 121
Market outlook 123
Five forces analysis 124
Macroeconomic indicators 132
Pharmaceuticals in Canada 134
Market Overview 134
Market Data 135
Market Segmentation 136
Market outlook 138
Five forces analysis 139
Macroeconomic indicators 147
Pharmaceuticals in China 149
Market Overview 149
Market Data 150
Market Segmentation 151
Market outlook 153
Five forces analysis 154
Macroeconomic indicators 162
Pharmaceuticals in The Netherlands 164
Market Overview 164
Market Data 165
Market Segmentation 166
Market outlook 168
Five forces analysis 169
Macroeconomic indicators 177
Pharmaceuticals in Spain 179
Market Overview 179
Market Data 180



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 3/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Market Segmentation 181
Market outlook 183
Five forces analysis 184
Macroeconomic indicators 192
Pharmaceuticals in The United Kingdom 194
Market Overview 194
Market Data 195
Market Segmentation 196
Market outlook 198
Five forces analysis 199
Macroeconomic indicators 207
Pharmaceuticals in The United States 209
Market Overview 209
Market Data 210
Market Segmentation 211
Market outlook 213
Five forces analysis 214
Macroeconomic indicators 222
Company Profiles 224
Leading companies 224
Appendix 267
Methodology 267




LIST OF TABLES


Table 1: Global pharmaceuticals market value: $ billion, 2007'11 21
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2011 22
Table 3: Global pharmaceuticals market share: % share, by value, 2011 23
Table 4: Global pharmaceuticals market value forecast: $ billion, 2011'16 24
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2007'11 34
Table 6: Asia'Pacific pharmaceuticals market geography segmentation: $ billion, 2011 35
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2011 36
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2011'16 37
Table 9: Europe pharmaceuticals market value: $ billion, 2007'11 47
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2011 48
Table 11: Europe pharmaceuticals market share: % share, by value, 2011 49
Table 12: Europe pharmaceuticals market value forecast: $ billion, 2011'16 50
Table 13: France pharmaceuticals market value: $ billion, 2007'11 60
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2011 61
Table 15: France pharmaceuticals market share: % share, by value, 2011 62
Table 16: France pharmaceuticals market value forecast: $ billion, 2011'16 63
Table 17: France size of population (million), 2007'11 72
Table 18: France gdp (constant 2000 prices, $ billion), 2007'11 72
Table 19: France gdp (current prices, $ billion), 2007'11 72
Table 20: France inflation, 2007'11 73
Table 21: France consumer price index (absolute), 2007'11 73



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 4/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Table 22: France exchange rate, 2007'11 73
Table 23: Germany pharmaceuticals market value: $ billion, 2007'11 75
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2011 76
Table 25: Germany pharmaceuticals market share: % share, by value, 2011 77
Table 26: Germany pharmaceuticals market value forecast: $ billion, 2011'16 78
Table 27: Germany size of population (million), 2007'11 87
Table 28: Germany gdp (constant 2000 prices, $ billion), 2007'11 87
Table 29: Germany gdp (current prices, $ billion), 2007'11 87
Table 30: Germany inflation, 2007'11 88
Table 31: Germany consumer price index (absolute), 2007'11 88
Table 32: Germany exchange rate, 2007'11 88
Table 33: Italy pharmaceuticals market value: $ billion, 2007'11 90
Table 34: Italy pharmaceuticals market geography segmentation: $ billion, 2011 91
Table 35: Italy pharmaceuticals market share: % share, by value, 2011 92
Table 36: Italy pharmaceuticals market value forecast: $ billion, 2011'16 93
Table 37: Italy size of population (million), 2007'11 102
Table 38: Italy gdp (constant 2000 prices, $ billion), 2007'11 102
Table 39: Italy gdp (current prices, $ billion), 2007'11 102
Table 40: Italy inflation, 2007'11 103
Table 41: Italy consumer price index (absolute), 2007'11 103
Table 42: Italy exchange rate, 2007'11 103
Table 43: Japan pharmaceuticals market value: $ billion, 2007'11 105
Table 44: Japan pharmaceuticals market geography segmentation: $ billion, 2011 106
Table 45: Japan pharmaceuticals market share: % share, by value, 2011 107
Table 46: Japan pharmaceuticals market value forecast: $ billion, 2011'16 108
Table 47: Japan size of population (million), 2007'11 117
Table 48: Japan gdp (constant 2000 prices, $ billion), 2007'11 117
Table 49: Japan gdp (current prices, $ billion), 2007'11 117
Table 50: Japan inflation, 2007'11 118
Table 51: Japan consumer price index (absolute), 2007'11 118
Table 52: Japan exchange rate, 2007'11 118
Table 53: Belgium pharmaceuticals market value: $ billion, 2007'11 120
Table 54: Belgium pharmaceuticals market geography segmentation: $ billion, 2011 121
Table 55: Belgium pharmaceuticals market share: % share, by value, 2011 122
Table 56: Belgium pharmaceuticals market value forecast: $ billion, 2011'16 123
Table 57: Belgium size of population (million), 2007'11 132
Table 58: Belgium gdp (constant 2000 prices, $ billion), 2007'11 132
Table 59: Belgium gdp (current prices, $ billion), 2007'11 132
Table 60: Belgium inflation, 2007'11 133
Table 61: Belgium consumer price index (absolute), 2007'11 133
Table 62: Belgium exchange rate, 2007'11 133
Table 63: Canada pharmaceuticals market value: $ billion, 2007'11 135
Table 64: Canada pharmaceuticals market geography segmentation: $ billion, 2011 136
Table 65: Canada pharmaceuticals market share: % share, by value, 2011 137
Table 66: Canada pharmaceuticals market value forecast: $ billion, 2011'16 138
Table 67: Canada size of population (million), 2007'11 147
Table 68: Canada gdp (constant 2000 prices, $ billion), 2007'11 147
Table 69: Canada gdp (current prices, $ billion), 2007'11 147



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 5/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Table 70: Canada inflation, 2007'11 148
Table 71: Canada consumer price index (absolute), 2007'11 148
Table 72: Canada exchange rate, 2007'11 148
Table 73: China pharmaceuticals market value: $ billion, 2007'11 150
Table 74: China pharmaceuticals market geography segmentation: $ billion, 2011 151
Table 75: China pharmaceuticals market share: % share, by value, 2011 152
Table 76: China pharmaceuticals market value forecast: $ billion, 2011'16 153
Table 77: China size of population (million), 2007'11 162
Table 78: China gdp (constant 2000 prices, $ billion), 2007'11 162
Table 79: China gdp (current prices, $ billion), 2007'11 162
Table 80: China inflation, 2007'11 163
Table 81: China consumer price index (absolute), 2007'11 163
Table 82: China exchange rate, 2007'11 163
Table 83: Netherlands pharmaceuticals market value: $ million, 2007'11 165
Table 84: Netherlands pharmaceuticals market geography segmentation: $ million, 2011 166
Table 85: Netherlands pharmaceuticals market share: % share, by value, 2011 167
Table 86: Netherlands pharmaceuticals market value forecast: $ million, 2011'16 168
Table 87: Netherlands size of population (million), 2007'11 177
Table 88: Netherlands gdp (constant 2000 prices, $ billion), 2007'11 177
Table 89: Netherlands gdp (current prices, $ billion), 2007'11 177
Table 90: Netherlands inflation, 2007'11 178
Table 91: Netherlands consumer price index (absolute), 2007'11 178
Table 92: Netherlands exchange rate, 2007'11 178
Table 93: Spain pharmaceuticals market value: $ billion, 2007'11 180
Table 94: Spain pharmaceuticals market geography segmentation: $ billion, 2011 181
Table 95: Spain pharmaceuticals market share: % share, by value, 2011 182
Table 96: Spain pharmaceuticals market value forecast: $ billion, 2011'16 183
Table 97: Spain size of population (million), 2007'11 192
Table 98: Spain gdp (constant 2000 prices, $ billion), 2007'11 192
Table 99: Spain gdp (current prices, $ billion), 2007'11 192
Table 100: Spain inflation, 2007'11 193
Table 101: Spain consumer price index (absolute), 2007'11 193
Table 102: Spain exchange rate, 2007'11 193
Table 103: United Kingdom pharmaceuticals market value: $ billion, 2007'11 195
Table 104: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2011 196
Table 105: United Kingdom pharmaceuticals market share: % share, by value, 2011 197
Table 106: United Kingdom pharmaceuticals market value forecast: $ billion, 2011'16 198
Table 107: United Kingdom size of population (million), 2007'11 207
Table 108: United Kingdom gdp (constant 2000 prices, $ billion), 2007'11 207
Table 109: United Kingdom gdp (current prices, $ billion), 2007'11 207
Table 110: United Kingdom inflation, 2007'11 208
Table 111: United Kingdom consumer price index (absolute), 2007'11 208
Table 112: United Kingdom exchange rate, 2007'11 208
Table 113: United States pharmaceuticals market value: $ billion, 2007'11 210
Table 114: United States pharmaceuticals market geography segmentation: $ billion, 2011 211
Table 115: United States pharmaceuticals market share: % share, by value, 2011 212
Table 116: United States pharmaceuticals market value forecast: $ billion, 2011'16 213
Table 117: United States size of population (million), 2007'11 222



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 6/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Table 118: United States gdp (constant 2000 prices, $ billion), 2007'11 222
Table 119: United States gdp (current prices, $ billion), 2007'11 222
Table 120: United States inflation, 2007'11 223
Table 121: United States consumer price index (absolute), 2007'11 223
Table 122: United States exchange rate, 2007'11 223
Table 123: Pfizer Inc.: key facts 224
Table 124: Pfizer Inc.: key financials ($) 225
Table 125: Pfizer Inc.: key financial ratios 225
Table 126: GlaxoSmithKline Plc: key facts 227
Table 127: GlaxoSmithKline Plc: key financials ($) 228
Table 128: GlaxoSmithKline Plc: key financials (£) 229
Table 129: GlaxoSmithKline Plc: key financial ratios 229
Table 130: AstraZeneca PLC: key facts 231
Table 131: AstraZeneca PLC: key financials ($) 232
Table 132: AstraZeneca PLC: key financial ratios 233
Table 133: Merck & Co., Inc.: key facts 235
Table 134: Merck & Co., Inc.: key financials ($) 236
Table 135: Merck & Co., Inc.: key financial ratios 236
Table 136: Daiichi Sankyo Co., Ltd.: key facts 238
Table 137: Daiichi Sankyo Co., Ltd.: key financials ($) 239
Table 138: Daiichi Sankyo Co., Ltd.: key financials (¥) 239
Table 139: Daiichi Sankyo Co., Ltd.: key financial ratios 239
Table 140: Astellas Pharma Inc.: key facts 241
Table 141: Astellas Pharma Inc.: key financials ($) 242
Table 142: Astellas Pharma Inc.: key financials (¥) 242
Table 143: Astellas Pharma Inc.: key financial ratios 242
Table 144: Novartis AG: key facts 244
Table 145: Novartis AG: key financials ($) 245
Table 146: Novartis AG: key financial ratios 245
Table 147: Chiesi Farmaceutici S.P.A.: key facts 247
Table 148: Menarini Group, The: key facts 249
Table 149: Takeda Pharmaceutical Company Limited: key facts 250
Table 150: Takeda Pharmaceutical Company Limited: key financials ($) 251
Table 151: Takeda Pharmaceutical Company Limited: key financials (¥) 251
Table 152: Takeda Pharmaceutical Company Limited: key financial ratios 251
Table 153: Mitsubishi Tanabe Pharma Corporation: key facts 253
Table 154: Mitsubishi Tanabe Pharma Corporation: key financials ($) 254
Table 155: Mitsubishi Tanabe Pharma Corporation: key financials (¥) 254
Table 156: Mitsubishi Tanabe Pharma Corporation: key financial ratios 254
Table 157: Johnson & Johnson: key facts 256
Table 158: Johnson & Johnson: key financials ($) 257
Table 159: Johnson & Johnson: key financial ratios 257
Table 160: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 259
Table 161: Almirall S.A.: key facts 260
Table 162: Almirall S.A.: key financials ($) 260
Table 163: Almirall S.A.: key financials (') 261
Table 164: Almirall S.A.: key financial ratios 261
Table 165: Sanofi: key facts 263



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 7/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Table 166: Sanofi: key financials ($) 264
Table 167: Sanofi: key financials (') 264
Table 168: Sanofi: key financial ratios 265


LIST OF FIGURES
Figure 1: Global pharmaceuticals market value: $ billion, 2007'11 25
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2011 26
Figure 3: Global pharmaceuticals market share: % share, by value, 2011 27
Figure 4: Global pharmaceuticals market value forecast: $ billion, 2011'16 28
Figure 5: Forces driving competition in the global pharmaceuticals market, 2011 29
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2011 30
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2011 32
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2011 33
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2011 35
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2011 36
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2007'11 38
Figure 12: Asia'Pacific pharmaceuticals market geography segmentation: % share, by value, 2011 39
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2011 40
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2011'16 41
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2011 42
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2011 43
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2011 45
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2011 46
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2011 48
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2011 49
Figure 21: Europe pharmaceuticals market value: $ billion, 2007'11 51
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2011 52
Figure 23: Europe pharmaceuticals market share: % share, by value, 2011 53
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2011'16 54
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2011 55
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2011 56
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2011 58
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2011 59
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2011 61
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2011 62
Figure 31: France pharmaceuticals market value: $ billion, 2007'11 64
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2011 65
Figure 33: France pharmaceuticals market share: % share, by value, 2011 66
Figure 34: France pharmaceuticals market value forecast: $ billion, 2011'16 67
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2011 68
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2011 69
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2011 71
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2011 72
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2011 74
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2011 75
Figure 41: Germany pharmaceuticals market value: $ billion, 2007'11 79
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2011 80
Figure 43: Germany pharmaceuticals market share: % share, by value, 2011 81



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 8/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2011'16 82
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2011 83
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2011 84
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2011 86
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2011 87
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2011 89
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2011 90
Figure 51: Italy pharmaceuticals market value: $ billion, 2007'11 94
Figure 52: Italy pharmaceuticals market geography segmentation: % share, by value, 2011 95
Figure 53: Italy pharmaceuticals market share: % share, by value, 2011 96
Figure 54: Italy pharmaceuticals market value forecast: $ billion, 2011'16 97
Figure 55: Forces driving competition in the pharmaceuticals market in Italy, 2011 98
Figure 56: Drivers of buyer power in the pharmaceuticals market in Italy, 2011 99
Figure 57: Drivers of supplier power in the pharmaceuticals market in Italy, 2011 101
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2011 102
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2011 104
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2011 105
Figure 61: Japan pharmaceuticals market value: $ billion, 2007'11 109
Figure 62: Japan pharmaceuticals market geography segmentation: % share, by value, 2011 110
Figure 63: Japan pharmaceuticals market share: % share, by value, 2011 111
Figure 64: Japan pharmaceuticals market value forecast: $ billion, 2011'16 112
Figure 65: Forces driving competition in the pharmaceuticals market in Japan, 2011 113
Figure 66: Drivers of buyer power in the pharmaceuticals market in Japan, 2011 114
Figure 67: Drivers of supplier power in the pharmaceuticals market in Japan, 2011 116
Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2011 117
Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2011 119
Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2011 120
Figure 71: Belgium pharmaceuticals market value: $ billion, 2007'11 124
Figure 72: Belgium pharmaceuticals market geography segmentation: % share, by value, 2011 125
Figure 73: Belgium pharmaceuticals market share: % share, by value, 2011 126
Figure 74: Belgium pharmaceuticals market value forecast: $ billion, 2011'16 127
Figure 75: Forces driving competition in the pharmaceuticals market in Belgium, 2011 128
Figure 76: Drivers of buyer power in the pharmaceuticals market in Belgium, 2011 129
Figure 77: Drivers of supplier power in the pharmaceuticals market in Belgium, 2011 131
Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Belgium, 2011 132
Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Belgium, 2011 134
Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Belgium, 2011 135
Figure 81: Canada pharmaceuticals market value: $ billion, 2007'11 139
Figure 82: Canada pharmaceuticals market geography segmentation: % share, by value, 2011 140
Figure 83: Canada pharmaceuticals market share: % share, by value, 2011 141
Figure 84: Canada pharmaceuticals market value forecast: $ billion, 2011'16 142
Figure 85: Forces driving competition in the pharmaceuticals market in Canada, 2011 143
Figure 86: Drivers of buyer power in the pharmaceuticals market in Canada, 2011 144
Figure 87: Drivers of supplier power in the pharmaceuticals market in Canada, 2011 146
Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2011 147
Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2011 149
Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2011 150
Figure 91: China pharmaceuticals market value: $ billion, 2007'11 154



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 9/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Figure 92: China pharmaceuticals market geography segmentation: % share, by value, 2011 155
Figure 93: China pharmaceuticals market share: % share, by value, 2011 156
Figure 94: China pharmaceuticals market value forecast: $ billion, 2011'16 157
Figure 95: Forces driving competition in the pharmaceuticals market in China, 2011 158
Figure 96: Drivers of buyer power in the pharmaceuticals market in China, 2011 159
Figure 97: Drivers of supplier power in the pharmaceuticals market in China, 2011 161
Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2011 162
Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2011 164
Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in China, 2011 165
Figure 101: Netherlands pharmaceuticals market value: $ million, 2007'11 169
Figure 102: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2011 170
Figure 103: Netherlands pharmaceuticals market share: % share, by value, 2011 171
Figure 104: Netherlands pharmaceuticals market value forecast: $ million, 2011'16 172
Figure 105: Forces driving competition in the pharmaceuticals market in the Netherlands, 2011 173
Figure 106: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2011 174
Figure 107: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2011 176
Figure 108: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2011 177
Figure 109: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2011 179
Figure 110: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2011 180
Figure 111: Spain pharmaceuticals market value: $ billion, 2007'11 184
Figure 112: Spain pharmaceuticals market geography segmentation: % share, by value, 2011 185
Figure 113: Spain pharmaceuticals market share: % share, by value, 2011 186
Figure 114: Spain pharmaceuticals market value forecast: $ billion, 2011'16 187
Figure 115: Forces driving competition in the pharmaceuticals market in Spain, 2011 188
Figure 116: Drivers of buyer power in the pharmaceuticals market in Spain, 2011 189
Figure 117: Drivers of supplier power in the pharmaceuticals market in Spain, 2011 191
Figure 118: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2011 192
Figure 119: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2011 194
Figure 120: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2011 195
Figure 121: United Kingdom pharmaceuticals market value: $ billion, 2007'11 199
Figure 122: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2011 200
Figure 123: United Kingdom pharmaceuticals market share: % share, by value, 2011 201
Figure 124: United Kingdom pharmaceuticals market value forecast: $ billion, 2011'16 202
Figure 125: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2011 203
Figure 126: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2011 204
Figure 127: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2011 206
Figure 128: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2011 207
Figure 129: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2011 209
Figure 130: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2011 210
Figure 131: United States pharmaceuticals market value: $ billion, 2007'11 214
Figure 132: United States pharmaceuticals market geography segmentation: % share, by value, 2011 215
Figure 133: United States pharmaceuticals market share: % share, by value, 2011 216
Figure 134: United States pharmaceuticals market value forecast: $ billion, 2011'16 217
Figure 135: Forces driving competition in the pharmaceuticals market in the United States, 2011 218
Figure 136: Drivers of buyer power in the pharmaceuticals market in the United States, 2011 219
Figure 137: Drivers of supplier power in the pharmaceuticals market in the United States, 2011 221
Figure 138: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2011 222
Figure 139: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2011 224



Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                           Page 10/13
Find Industry reports, Company profiles
ReportLinker                                                                                  and Market Statistics
                                              >> Get this Report Now by email!

Figure 140: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2011 225
Figure 141: Pfizer Inc.: revenues & profitability 230
Figure 142: Pfizer Inc.: assets & liabilities 230
Figure 143: GlaxoSmithKline Plc: revenues & profitability 233
Figure 144: GlaxoSmithKline Plc: assets & liabilities 234
Figure 145: AstraZeneca PLC: revenues & profitability 237
Figure 146: AstraZeneca PLC: assets & liabilities 238
Figure 147: Merck & Co., Inc.: revenues & profitability 240
Figure 148: Merck & Co., Inc.: assets & liabilities 241
Figure 149: Daiichi Sankyo Co., Ltd.: revenues & profitability 244
Figure 150: Daiichi Sankyo Co., Ltd.: assets & liabilities 244
Figure 151: Astellas Pharma Inc.: revenues & profitability 247
Figure 152: Astellas Pharma Inc.: assets & liabilities 247
Figure 153: Novartis AG: revenues & profitability 250
Figure 154: Novartis AG: assets & liabilities 250
Figure 155: Takeda Pharmaceutical Company Limited: revenues & profitability 256
Figure 156: Takeda Pharmaceutical Company Limited: assets & liabilities 256
Figure 157: Mitsubishi Tanabe Pharma Corporation: revenues & profitability 259
Figure 158: Mitsubishi Tanabe Pharma Corporation: assets & liabilities 259
Figure 159: Johnson & Johnson: revenues & profitability 261
Figure 160: Johnson & Johnson: assets & liabilities 262
Figure 161: Almirall S.A.: revenues & profitability 265
Figure 162: Almirall S.A.: assets & liabilities 266
Figure 163: Sanofi: revenues & profitability 269
Figure 164: Sanofi: assets & liabilities 270




Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                     Page 11/13
Find Industry reports, Company profiles
ReportLinker                                                                                         and Market Statistics
                                              >> Get this Report Now by email!
              Fax Order Form
              To place an order via fax simply print this form, fill in the information below and fax the completed form to:
                           Europe, Middle East and Africa : + 33 4 37 37 15 56
                           Asia, Oceania and America : + 1 (805) 617 17 93
              If you have any questions please visit http://www.reportlinker.com/notify/contact


              Order Information
              Please verify that the product information is correct and select the format(s) you require.

                    Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides




              Product Formats
              Please select the product formats and the quantity you require.

                                     1 User License--USD 1 495.00                           Quantity: _____



                                     Corporate License--USD 3 737.50                        Quantity: _____




              Contact Information
              Please enter all the information below in BLOCK CAPITALS


              Title:                   Mr                        Mrs                   Dr             Miss     Ms              Prof

              First Name:                   _____________________________ Last Name: __________________________________

              Email Address:               __________________________________________________________________________

              Job Title:                   __________________________________________________________________________

              Organization:                __________________________________________________________________________

              Address:                     __________________________________________________________________________

              City:                        __________________________________________________________________________

              Postal / Zip Code:            __________________________________________________________________________

              Country:                     __________________________________________________________________________

              Phone Number:                __________________________________________________________________________

              Fax Number:                  __________________________________________________________________________




Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                                  Page 12/13
Find Industry reports, Company profiles
ReportLinker                                                                                            and Market Statistics
                                              >> Get this Report Now by email!
              Payment Information
              Please indicate the payment method, you would like to use by selecting the appropriate box.




                     Payment by credit card                        Card Number: ______________________________________________


                                                                   Expiry Date         __________ / _________


                                                                   CVV Number _____________________


                                                                   Card Type (ex: Visa, Amex…) _________________________________




                     Payment by wire transfer                      Crédit Mutuel
                                                                   RIB : 10278 07314 00020257701 89
                                                                   BIC : CMCIFR2A
                                                                   IBAN : FR76 1027 8073 1400 0202 5770 189




                      Payment by check                             UBIQUICK SAS
                                                                   16 rue Grenette – 69002 LYON, FRANCE




                                   Customer signature:

                                    




              Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
              http://www.reportlinker.com/index/terms




                                                                      Please fax this form to:

                                                       Europe, Middle East and Africa : + 33 4 37 37 15 56

                                                          Asia, Oceania and America : + 1 (805) 617 17 93




Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare)                                               Page 13/13

Weitere ähnliche Inhalte

Mehr von ReportLinker.com

Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryReportLinker.com
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming IndustryReportLinker.com
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013ReportLinker.com
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013ReportLinker.com
 
Global Renewable Energy Report
Global Renewable Energy ReportGlobal Renewable Energy Report
Global Renewable Energy ReportReportLinker.com
 
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
 
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013ReportLinker.com
 

Mehr von ReportLinker.com (20)

 
Thisisatest
ThisisatestThisisatest
Thisisatest
 
Global Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes IndustryGlobal Electric Resistance Welded Pipes Industry
Global Electric Resistance Welded Pipes Industry
 
Global Wireless Gaming Industry
Global Wireless Gaming IndustryGlobal Wireless Gaming Industry
Global Wireless Gaming Industry
 
Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013Hyperalgesia Global Clinical Trials Review, H1, 2013
Hyperalgesia Global Clinical Trials Review, H1, 2013
 
Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013Genital Herpes Global Clinical Trials Review, H1, 2013
Genital Herpes Global Clinical Trials Review, H1, 2013
 
The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...The Future of Direct Communications Technologies and Proximity-based Applicat...
The Future of Direct Communications Technologies and Proximity-based Applicat...
 
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...
 
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...
 
Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013Bradycardia Global Clinical Trials Review, H1, 2013
Bradycardia Global Clinical Trials Review, H1, 2013
 
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
 
China iron ore mining industry, 2013
China iron ore mining industry, 2013China iron ore mining industry, 2013
China iron ore mining industry, 2013
 
World Biomass Report
World Biomass ReportWorld Biomass Report
World Biomass Report
 
World Biofuels Report
World Biofuels ReportWorld Biofuels Report
World Biofuels Report
 
Global Renewable Energy Report
Global Renewable Energy ReportGlobal Renewable Energy Report
Global Renewable Energy Report
 
Solar PV Report
Solar PV ReportSolar PV Report
Solar PV Report
 
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013Inguinal Hernia Global Clinical Trials Review, H1, 2013
Inguinal Hernia Global Clinical Trials Review, H1, 2013
 
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013Cancer Cachexia Global Clinical Trials Review, H1, 2013
Cancer Cachexia Global Clinical Trials Review, H1, 2013
 
Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013
Pompe Disease Global Clinical Trials Review, H1, 2013
 
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
Abdominal Aortic Aneurysms Global Clinical Trials Review, H1, 2013
 

Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides

  • 1. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides Published on November 2012 Report Summary Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis. Scope of the Report * Contains an executive summary and data on value, volume and segmentation * Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies * Incorporates in-depth five forces competitive environment analysis and scorecards * Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US). * Includes a five-year forecast of the industry Highlights The global pharmaceuticals market grew by 3.5% in 2011 to reach a value of $782.1 billion. In 2016, the global pharmaceuticals market is forecast to have a value of $971.1 billion, an increase of 24.2% since 2011. Americas accounts for 42.2% of the global pharmaceuticals market value. Pfizer is the leading player in the global pharmaceuticals market, generating a 8.7% share of the market's value. Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level research Market Definition The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 1/13
  • 2. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2011 annual average exchange rates. Table of Content TABLE OF CONTENTS EXECUTIVE SUMMARY 2 Market value 2 Market value forecast 2 Geography segmentation 2 Market share 2 Introduction 19 What is this report about' 19 Who is the target reader' 19 How to use this report 19 Definitions 19 Global Pharmaceuticals 20 Market Overview 20 Market Data 21 Market Segmentation 22 Market outlook 24 Five forces analysis 25 Pharmaceuticals in Asia-Pacific 33 Market Overview 33 Market Data 34 Market Segmentation 35 Market outlook 37 Five forces analysis 38 Pharmaceuticals in Europe 46 Market Overview 46 Market Data 47 Market Segmentation 48 Market outlook 50 Five forces analysis 51 Pharmaceuticals in France 59 Market Overview 59 Market Data 60 Market Segmentation 61 Market outlook 63 Five forces analysis 64 Macroeconomic indicators 72 Pharmaceuticals in Germany 74 Market Overview 74 Market Data 75 Market Segmentation 76 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 2/13
  • 3. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Market outlook 78 Five forces analysis 79 Macroeconomic indicators 87 Pharmaceuticals in Italy 89 Market Overview 89 Market Data 90 Market Segmentation 91 Market outlook 93 Five forces analysis 94 Macroeconomic indicators 102 Pharmaceuticals in Japan 104 Market Overview 104 Market Data 105 Market Segmentation 106 Market outlook 108 Five forces analysis 109 Macroeconomic indicators 117 Pharmaceuticals in Belgium 119 Market Overview 119 Market Data 120 Market Segmentation 121 Market outlook 123 Five forces analysis 124 Macroeconomic indicators 132 Pharmaceuticals in Canada 134 Market Overview 134 Market Data 135 Market Segmentation 136 Market outlook 138 Five forces analysis 139 Macroeconomic indicators 147 Pharmaceuticals in China 149 Market Overview 149 Market Data 150 Market Segmentation 151 Market outlook 153 Five forces analysis 154 Macroeconomic indicators 162 Pharmaceuticals in The Netherlands 164 Market Overview 164 Market Data 165 Market Segmentation 166 Market outlook 168 Five forces analysis 169 Macroeconomic indicators 177 Pharmaceuticals in Spain 179 Market Overview 179 Market Data 180 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 3/13
  • 4. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Market Segmentation 181 Market outlook 183 Five forces analysis 184 Macroeconomic indicators 192 Pharmaceuticals in The United Kingdom 194 Market Overview 194 Market Data 195 Market Segmentation 196 Market outlook 198 Five forces analysis 199 Macroeconomic indicators 207 Pharmaceuticals in The United States 209 Market Overview 209 Market Data 210 Market Segmentation 211 Market outlook 213 Five forces analysis 214 Macroeconomic indicators 222 Company Profiles 224 Leading companies 224 Appendix 267 Methodology 267 LIST OF TABLES Table 1: Global pharmaceuticals market value: $ billion, 2007'11 21 Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2011 22 Table 3: Global pharmaceuticals market share: % share, by value, 2011 23 Table 4: Global pharmaceuticals market value forecast: $ billion, 2011'16 24 Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 2007'11 34 Table 6: Asia'Pacific pharmaceuticals market geography segmentation: $ billion, 2011 35 Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2011 36 Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2011'16 37 Table 9: Europe pharmaceuticals market value: $ billion, 2007'11 47 Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2011 48 Table 11: Europe pharmaceuticals market share: % share, by value, 2011 49 Table 12: Europe pharmaceuticals market value forecast: $ billion, 2011'16 50 Table 13: France pharmaceuticals market value: $ billion, 2007'11 60 Table 14: France pharmaceuticals market geography segmentation: $ billion, 2011 61 Table 15: France pharmaceuticals market share: % share, by value, 2011 62 Table 16: France pharmaceuticals market value forecast: $ billion, 2011'16 63 Table 17: France size of population (million), 2007'11 72 Table 18: France gdp (constant 2000 prices, $ billion), 2007'11 72 Table 19: France gdp (current prices, $ billion), 2007'11 72 Table 20: France inflation, 2007'11 73 Table 21: France consumer price index (absolute), 2007'11 73 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 4/13
  • 5. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Table 22: France exchange rate, 2007'11 73 Table 23: Germany pharmaceuticals market value: $ billion, 2007'11 75 Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2011 76 Table 25: Germany pharmaceuticals market share: % share, by value, 2011 77 Table 26: Germany pharmaceuticals market value forecast: $ billion, 2011'16 78 Table 27: Germany size of population (million), 2007'11 87 Table 28: Germany gdp (constant 2000 prices, $ billion), 2007'11 87 Table 29: Germany gdp (current prices, $ billion), 2007'11 87 Table 30: Germany inflation, 2007'11 88 Table 31: Germany consumer price index (absolute), 2007'11 88 Table 32: Germany exchange rate, 2007'11 88 Table 33: Italy pharmaceuticals market value: $ billion, 2007'11 90 Table 34: Italy pharmaceuticals market geography segmentation: $ billion, 2011 91 Table 35: Italy pharmaceuticals market share: % share, by value, 2011 92 Table 36: Italy pharmaceuticals market value forecast: $ billion, 2011'16 93 Table 37: Italy size of population (million), 2007'11 102 Table 38: Italy gdp (constant 2000 prices, $ billion), 2007'11 102 Table 39: Italy gdp (current prices, $ billion), 2007'11 102 Table 40: Italy inflation, 2007'11 103 Table 41: Italy consumer price index (absolute), 2007'11 103 Table 42: Italy exchange rate, 2007'11 103 Table 43: Japan pharmaceuticals market value: $ billion, 2007'11 105 Table 44: Japan pharmaceuticals market geography segmentation: $ billion, 2011 106 Table 45: Japan pharmaceuticals market share: % share, by value, 2011 107 Table 46: Japan pharmaceuticals market value forecast: $ billion, 2011'16 108 Table 47: Japan size of population (million), 2007'11 117 Table 48: Japan gdp (constant 2000 prices, $ billion), 2007'11 117 Table 49: Japan gdp (current prices, $ billion), 2007'11 117 Table 50: Japan inflation, 2007'11 118 Table 51: Japan consumer price index (absolute), 2007'11 118 Table 52: Japan exchange rate, 2007'11 118 Table 53: Belgium pharmaceuticals market value: $ billion, 2007'11 120 Table 54: Belgium pharmaceuticals market geography segmentation: $ billion, 2011 121 Table 55: Belgium pharmaceuticals market share: % share, by value, 2011 122 Table 56: Belgium pharmaceuticals market value forecast: $ billion, 2011'16 123 Table 57: Belgium size of population (million), 2007'11 132 Table 58: Belgium gdp (constant 2000 prices, $ billion), 2007'11 132 Table 59: Belgium gdp (current prices, $ billion), 2007'11 132 Table 60: Belgium inflation, 2007'11 133 Table 61: Belgium consumer price index (absolute), 2007'11 133 Table 62: Belgium exchange rate, 2007'11 133 Table 63: Canada pharmaceuticals market value: $ billion, 2007'11 135 Table 64: Canada pharmaceuticals market geography segmentation: $ billion, 2011 136 Table 65: Canada pharmaceuticals market share: % share, by value, 2011 137 Table 66: Canada pharmaceuticals market value forecast: $ billion, 2011'16 138 Table 67: Canada size of population (million), 2007'11 147 Table 68: Canada gdp (constant 2000 prices, $ billion), 2007'11 147 Table 69: Canada gdp (current prices, $ billion), 2007'11 147 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 5/13
  • 6. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Table 70: Canada inflation, 2007'11 148 Table 71: Canada consumer price index (absolute), 2007'11 148 Table 72: Canada exchange rate, 2007'11 148 Table 73: China pharmaceuticals market value: $ billion, 2007'11 150 Table 74: China pharmaceuticals market geography segmentation: $ billion, 2011 151 Table 75: China pharmaceuticals market share: % share, by value, 2011 152 Table 76: China pharmaceuticals market value forecast: $ billion, 2011'16 153 Table 77: China size of population (million), 2007'11 162 Table 78: China gdp (constant 2000 prices, $ billion), 2007'11 162 Table 79: China gdp (current prices, $ billion), 2007'11 162 Table 80: China inflation, 2007'11 163 Table 81: China consumer price index (absolute), 2007'11 163 Table 82: China exchange rate, 2007'11 163 Table 83: Netherlands pharmaceuticals market value: $ million, 2007'11 165 Table 84: Netherlands pharmaceuticals market geography segmentation: $ million, 2011 166 Table 85: Netherlands pharmaceuticals market share: % share, by value, 2011 167 Table 86: Netherlands pharmaceuticals market value forecast: $ million, 2011'16 168 Table 87: Netherlands size of population (million), 2007'11 177 Table 88: Netherlands gdp (constant 2000 prices, $ billion), 2007'11 177 Table 89: Netherlands gdp (current prices, $ billion), 2007'11 177 Table 90: Netherlands inflation, 2007'11 178 Table 91: Netherlands consumer price index (absolute), 2007'11 178 Table 92: Netherlands exchange rate, 2007'11 178 Table 93: Spain pharmaceuticals market value: $ billion, 2007'11 180 Table 94: Spain pharmaceuticals market geography segmentation: $ billion, 2011 181 Table 95: Spain pharmaceuticals market share: % share, by value, 2011 182 Table 96: Spain pharmaceuticals market value forecast: $ billion, 2011'16 183 Table 97: Spain size of population (million), 2007'11 192 Table 98: Spain gdp (constant 2000 prices, $ billion), 2007'11 192 Table 99: Spain gdp (current prices, $ billion), 2007'11 192 Table 100: Spain inflation, 2007'11 193 Table 101: Spain consumer price index (absolute), 2007'11 193 Table 102: Spain exchange rate, 2007'11 193 Table 103: United Kingdom pharmaceuticals market value: $ billion, 2007'11 195 Table 104: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2011 196 Table 105: United Kingdom pharmaceuticals market share: % share, by value, 2011 197 Table 106: United Kingdom pharmaceuticals market value forecast: $ billion, 2011'16 198 Table 107: United Kingdom size of population (million), 2007'11 207 Table 108: United Kingdom gdp (constant 2000 prices, $ billion), 2007'11 207 Table 109: United Kingdom gdp (current prices, $ billion), 2007'11 207 Table 110: United Kingdom inflation, 2007'11 208 Table 111: United Kingdom consumer price index (absolute), 2007'11 208 Table 112: United Kingdom exchange rate, 2007'11 208 Table 113: United States pharmaceuticals market value: $ billion, 2007'11 210 Table 114: United States pharmaceuticals market geography segmentation: $ billion, 2011 211 Table 115: United States pharmaceuticals market share: % share, by value, 2011 212 Table 116: United States pharmaceuticals market value forecast: $ billion, 2011'16 213 Table 117: United States size of population (million), 2007'11 222 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 6/13
  • 7. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Table 118: United States gdp (constant 2000 prices, $ billion), 2007'11 222 Table 119: United States gdp (current prices, $ billion), 2007'11 222 Table 120: United States inflation, 2007'11 223 Table 121: United States consumer price index (absolute), 2007'11 223 Table 122: United States exchange rate, 2007'11 223 Table 123: Pfizer Inc.: key facts 224 Table 124: Pfizer Inc.: key financials ($) 225 Table 125: Pfizer Inc.: key financial ratios 225 Table 126: GlaxoSmithKline Plc: key facts 227 Table 127: GlaxoSmithKline Plc: key financials ($) 228 Table 128: GlaxoSmithKline Plc: key financials (£) 229 Table 129: GlaxoSmithKline Plc: key financial ratios 229 Table 130: AstraZeneca PLC: key facts 231 Table 131: AstraZeneca PLC: key financials ($) 232 Table 132: AstraZeneca PLC: key financial ratios 233 Table 133: Merck & Co., Inc.: key facts 235 Table 134: Merck & Co., Inc.: key financials ($) 236 Table 135: Merck & Co., Inc.: key financial ratios 236 Table 136: Daiichi Sankyo Co., Ltd.: key facts 238 Table 137: Daiichi Sankyo Co., Ltd.: key financials ($) 239 Table 138: Daiichi Sankyo Co., Ltd.: key financials (¥) 239 Table 139: Daiichi Sankyo Co., Ltd.: key financial ratios 239 Table 140: Astellas Pharma Inc.: key facts 241 Table 141: Astellas Pharma Inc.: key financials ($) 242 Table 142: Astellas Pharma Inc.: key financials (¥) 242 Table 143: Astellas Pharma Inc.: key financial ratios 242 Table 144: Novartis AG: key facts 244 Table 145: Novartis AG: key financials ($) 245 Table 146: Novartis AG: key financial ratios 245 Table 147: Chiesi Farmaceutici S.P.A.: key facts 247 Table 148: Menarini Group, The: key facts 249 Table 149: Takeda Pharmaceutical Company Limited: key facts 250 Table 150: Takeda Pharmaceutical Company Limited: key financials ($) 251 Table 151: Takeda Pharmaceutical Company Limited: key financials (¥) 251 Table 152: Takeda Pharmaceutical Company Limited: key financial ratios 251 Table 153: Mitsubishi Tanabe Pharma Corporation: key facts 253 Table 154: Mitsubishi Tanabe Pharma Corporation: key financials ($) 254 Table 155: Mitsubishi Tanabe Pharma Corporation: key financials (¥) 254 Table 156: Mitsubishi Tanabe Pharma Corporation: key financial ratios 254 Table 157: Johnson & Johnson: key facts 256 Table 158: Johnson & Johnson: key financials ($) 257 Table 159: Johnson & Johnson: key financial ratios 257 Table 160: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 259 Table 161: Almirall S.A.: key facts 260 Table 162: Almirall S.A.: key financials ($) 260 Table 163: Almirall S.A.: key financials (') 261 Table 164: Almirall S.A.: key financial ratios 261 Table 165: Sanofi: key facts 263 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 7/13
  • 8. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Table 166: Sanofi: key financials ($) 264 Table 167: Sanofi: key financials (') 264 Table 168: Sanofi: key financial ratios 265 LIST OF FIGURES Figure 1: Global pharmaceuticals market value: $ billion, 2007'11 25 Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2011 26 Figure 3: Global pharmaceuticals market share: % share, by value, 2011 27 Figure 4: Global pharmaceuticals market value forecast: $ billion, 2011'16 28 Figure 5: Forces driving competition in the global pharmaceuticals market, 2011 29 Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2011 30 Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2011 32 Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2011 33 Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2011 35 Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2011 36 Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 2007'11 38 Figure 12: Asia'Pacific pharmaceuticals market geography segmentation: % share, by value, 2011 39 Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2011 40 Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2011'16 41 Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2011 42 Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2011 43 Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2011 45 Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2011 46 Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2011 48 Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2011 49 Figure 21: Europe pharmaceuticals market value: $ billion, 2007'11 51 Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2011 52 Figure 23: Europe pharmaceuticals market share: % share, by value, 2011 53 Figure 24: Europe pharmaceuticals market value forecast: $ billion, 2011'16 54 Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2011 55 Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2011 56 Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2011 58 Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2011 59 Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2011 61 Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2011 62 Figure 31: France pharmaceuticals market value: $ billion, 2007'11 64 Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2011 65 Figure 33: France pharmaceuticals market share: % share, by value, 2011 66 Figure 34: France pharmaceuticals market value forecast: $ billion, 2011'16 67 Figure 35: Forces driving competition in the pharmaceuticals market in France, 2011 68 Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2011 69 Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2011 71 Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2011 72 Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2011 74 Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2011 75 Figure 41: Germany pharmaceuticals market value: $ billion, 2007'11 79 Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2011 80 Figure 43: Germany pharmaceuticals market share: % share, by value, 2011 81 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 8/13
  • 9. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Figure 44: Germany pharmaceuticals market value forecast: $ billion, 2011'16 82 Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2011 83 Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2011 84 Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2011 86 Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2011 87 Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2011 89 Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2011 90 Figure 51: Italy pharmaceuticals market value: $ billion, 2007'11 94 Figure 52: Italy pharmaceuticals market geography segmentation: % share, by value, 2011 95 Figure 53: Italy pharmaceuticals market share: % share, by value, 2011 96 Figure 54: Italy pharmaceuticals market value forecast: $ billion, 2011'16 97 Figure 55: Forces driving competition in the pharmaceuticals market in Italy, 2011 98 Figure 56: Drivers of buyer power in the pharmaceuticals market in Italy, 2011 99 Figure 57: Drivers of supplier power in the pharmaceuticals market in Italy, 2011 101 Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2011 102 Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2011 104 Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2011 105 Figure 61: Japan pharmaceuticals market value: $ billion, 2007'11 109 Figure 62: Japan pharmaceuticals market geography segmentation: % share, by value, 2011 110 Figure 63: Japan pharmaceuticals market share: % share, by value, 2011 111 Figure 64: Japan pharmaceuticals market value forecast: $ billion, 2011'16 112 Figure 65: Forces driving competition in the pharmaceuticals market in Japan, 2011 113 Figure 66: Drivers of buyer power in the pharmaceuticals market in Japan, 2011 114 Figure 67: Drivers of supplier power in the pharmaceuticals market in Japan, 2011 116 Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2011 117 Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2011 119 Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2011 120 Figure 71: Belgium pharmaceuticals market value: $ billion, 2007'11 124 Figure 72: Belgium pharmaceuticals market geography segmentation: % share, by value, 2011 125 Figure 73: Belgium pharmaceuticals market share: % share, by value, 2011 126 Figure 74: Belgium pharmaceuticals market value forecast: $ billion, 2011'16 127 Figure 75: Forces driving competition in the pharmaceuticals market in Belgium, 2011 128 Figure 76: Drivers of buyer power in the pharmaceuticals market in Belgium, 2011 129 Figure 77: Drivers of supplier power in the pharmaceuticals market in Belgium, 2011 131 Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Belgium, 2011 132 Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Belgium, 2011 134 Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Belgium, 2011 135 Figure 81: Canada pharmaceuticals market value: $ billion, 2007'11 139 Figure 82: Canada pharmaceuticals market geography segmentation: % share, by value, 2011 140 Figure 83: Canada pharmaceuticals market share: % share, by value, 2011 141 Figure 84: Canada pharmaceuticals market value forecast: $ billion, 2011'16 142 Figure 85: Forces driving competition in the pharmaceuticals market in Canada, 2011 143 Figure 86: Drivers of buyer power in the pharmaceuticals market in Canada, 2011 144 Figure 87: Drivers of supplier power in the pharmaceuticals market in Canada, 2011 146 Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2011 147 Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2011 149 Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2011 150 Figure 91: China pharmaceuticals market value: $ billion, 2007'11 154 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 9/13
  • 10. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Figure 92: China pharmaceuticals market geography segmentation: % share, by value, 2011 155 Figure 93: China pharmaceuticals market share: % share, by value, 2011 156 Figure 94: China pharmaceuticals market value forecast: $ billion, 2011'16 157 Figure 95: Forces driving competition in the pharmaceuticals market in China, 2011 158 Figure 96: Drivers of buyer power in the pharmaceuticals market in China, 2011 159 Figure 97: Drivers of supplier power in the pharmaceuticals market in China, 2011 161 Figure 98: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2011 162 Figure 99: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2011 164 Figure 100: Drivers of degree of rivalry in the pharmaceuticals market in China, 2011 165 Figure 101: Netherlands pharmaceuticals market value: $ million, 2007'11 169 Figure 102: Netherlands pharmaceuticals market geography segmentation: % share, by value, 2011 170 Figure 103: Netherlands pharmaceuticals market share: % share, by value, 2011 171 Figure 104: Netherlands pharmaceuticals market value forecast: $ million, 2011'16 172 Figure 105: Forces driving competition in the pharmaceuticals market in the Netherlands, 2011 173 Figure 106: Drivers of buyer power in the pharmaceuticals market in the Netherlands, 2011 174 Figure 107: Drivers of supplier power in the pharmaceuticals market in the Netherlands, 2011 176 Figure 108: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the Netherlands, 2011 177 Figure 109: Factors influencing the threat of substitutes in the pharmaceuticals market in the Netherlands, 2011 179 Figure 110: Drivers of degree of rivalry in the pharmaceuticals market in the Netherlands, 2011 180 Figure 111: Spain pharmaceuticals market value: $ billion, 2007'11 184 Figure 112: Spain pharmaceuticals market geography segmentation: % share, by value, 2011 185 Figure 113: Spain pharmaceuticals market share: % share, by value, 2011 186 Figure 114: Spain pharmaceuticals market value forecast: $ billion, 2011'16 187 Figure 115: Forces driving competition in the pharmaceuticals market in Spain, 2011 188 Figure 116: Drivers of buyer power in the pharmaceuticals market in Spain, 2011 189 Figure 117: Drivers of supplier power in the pharmaceuticals market in Spain, 2011 191 Figure 118: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Spain, 2011 192 Figure 119: Factors influencing the threat of substitutes in the pharmaceuticals market in Spain, 2011 194 Figure 120: Drivers of degree of rivalry in the pharmaceuticals market in Spain, 2011 195 Figure 121: United Kingdom pharmaceuticals market value: $ billion, 2007'11 199 Figure 122: United Kingdom pharmaceuticals market geography segmentation: % share, by value, 2011 200 Figure 123: United Kingdom pharmaceuticals market share: % share, by value, 2011 201 Figure 124: United Kingdom pharmaceuticals market value forecast: $ billion, 2011'16 202 Figure 125: Forces driving competition in the pharmaceuticals market in the United Kingdom, 2011 203 Figure 126: Drivers of buyer power in the pharmaceuticals market in the United Kingdom, 2011 204 Figure 127: Drivers of supplier power in the pharmaceuticals market in the United Kingdom, 2011 206 Figure 128: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United Kingdom, 2011 207 Figure 129: Factors influencing the threat of substitutes in the pharmaceuticals market in the United Kingdom, 2011 209 Figure 130: Drivers of degree of rivalry in the pharmaceuticals market in the United Kingdom, 2011 210 Figure 131: United States pharmaceuticals market value: $ billion, 2007'11 214 Figure 132: United States pharmaceuticals market geography segmentation: % share, by value, 2011 215 Figure 133: United States pharmaceuticals market share: % share, by value, 2011 216 Figure 134: United States pharmaceuticals market value forecast: $ billion, 2011'16 217 Figure 135: Forces driving competition in the pharmaceuticals market in the United States, 2011 218 Figure 136: Drivers of buyer power in the pharmaceuticals market in the United States, 2011 219 Figure 137: Drivers of supplier power in the pharmaceuticals market in the United States, 2011 221 Figure 138: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2011 222 Figure 139: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2011 224 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 10/13
  • 11. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Figure 140: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2011 225 Figure 141: Pfizer Inc.: revenues & profitability 230 Figure 142: Pfizer Inc.: assets & liabilities 230 Figure 143: GlaxoSmithKline Plc: revenues & profitability 233 Figure 144: GlaxoSmithKline Plc: assets & liabilities 234 Figure 145: AstraZeneca PLC: revenues & profitability 237 Figure 146: AstraZeneca PLC: assets & liabilities 238 Figure 147: Merck & Co., Inc.: revenues & profitability 240 Figure 148: Merck & Co., Inc.: assets & liabilities 241 Figure 149: Daiichi Sankyo Co., Ltd.: revenues & profitability 244 Figure 150: Daiichi Sankyo Co., Ltd.: assets & liabilities 244 Figure 151: Astellas Pharma Inc.: revenues & profitability 247 Figure 152: Astellas Pharma Inc.: assets & liabilities 247 Figure 153: Novartis AG: revenues & profitability 250 Figure 154: Novartis AG: assets & liabilities 250 Figure 155: Takeda Pharmaceutical Company Limited: revenues & profitability 256 Figure 156: Takeda Pharmaceutical Company Limited: assets & liabilities 256 Figure 157: Mitsubishi Tanabe Pharma Corporation: revenues & profitability 259 Figure 158: Mitsubishi Tanabe Pharma Corporation: assets & liabilities 259 Figure 159: Johnson & Johnson: revenues & profitability 261 Figure 160: Johnson & Johnson: assets & liabilities 262 Figure 161: Almirall S.A.: revenues & profitability 265 Figure 162: Almirall S.A.: assets & liabilities 266 Figure 163: Sanofi: revenues & profitability 269 Figure 164: Sanofi: assets & liabilities 270 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 11/13
  • 12. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides Product Formats Please select the product formats and the quantity you require. 1 User License--USD 1 495.00 Quantity: _____ Corporate License--USD 3 737.50 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 12/13
  • 13. Find Industry reports, Company profiles ReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 Pharmaceuticals: Global Industry Guide, MarketLine Industry Guides (From Slideshare) Page 13/13